UNC Charlotte Biochemist’s Research Holds Promise For Novel Treatments for Cancers and Neurological Diseases, Shaping Global Work On “The Chaperone Code”
For UNC Charlotte biochemist Andrew Truman, a quest for new and better treatments for cancers and neurological diseases drives his research into protein folding and the DNA damage response, along with his desire to advance science broadly. To fund his work, he has received three significant National Institutes of Health (NIH) grants expected to total $2M. “These are real things that affect real people. They are not theoretical,” Truman says.